This article analyzes the data from two studies comparing rilpivirine and efavirenz treatment regimens in HIV patients with viral loads under 100,000 copies/mL.......[Read More]

To better avoid getting or transmitting HIV, it’s important not only to use condoms consistently, but to avoid common mistakes that often occur.......[Read More]

Find out how immunotherapy dosing, premedication, and scheduling can impact patient safety.......[Read More]

Is it worth delaying the initiation of therapy until the results of that test are available?......[Read More]

Immunotherapy based strategies for sepsis treatment may become more common in the near future.......[Read More]

Can DRV be administered in HIV patients allergic to TMP-SMX? This study examines the cross-reactivity between both drugs.......[Read More]

Restoring and preserving immune function is a key component to successfully managing HIV-1 disease.......[Read More]

Last month I discussed the growing importance of multidrug resistance among patients with newly acquired HIV infections as well as in those receiving long-term HAART.......[Read More]

Olysio (simeprevir) is protease inhibitor-class drug used in combination antiviral therapy for the treatment of hepatitis C (HCV).......[Read More]

In this review and commentary: Restoration of limb fat occurred slowly in patients who switched from a thymidine NRTI to abacavir or tenofovir DF.......[Read More]

What is the prevalence of abnormal renal function among ART-naive, HIV-infected patients in Southeast Nigeria?......[Read More]

Maraviroc proves effective in treatment-naïve CCR5-tropic HIV-1 infection but what about the "hassle factor" of using it?......[Read More]

The early symptoms of HIV resemble many common viral illnesses and may not cause you to suspect that you are infected with a life-threatening disease. Although you may not get a positive laboratory test result for HIV until up to six months after you were infected, you may experience some early sym......[Read More]

AIDS prevention is designed to help protect individuals from being infected with the human immunodeficiency virus (HIV), which is the virus that causes AIDS or acquired immunodeficiency syndrome. AIDS causes multiple issues in the human body, including severely decreased immunity to sickness, infe......[Read More]

Nucleoside analogues are an important backbone of HAART, the use of which has led to a significant decline in the mortality associated with HIV disease.......[Read More]

Read the latest resistance data on protease inhibitors and entry inhibitors in these summaries from the 12th International HIV Drug Resistance Workshop.......[Read More]

HIV treatment has changed as researchers discover more about the condition. Doctors use antiretroviral therapy to treat HIV, involving different classes and combinations of medications. Physicians make treatment decisions based on the patient's current condition, prior treatment and the stage of th......[Read More]

Dr. Bartlett reviews the latest data on cardiovascular risk, hepatitis warning for nevirapine, HIV/hepatitis C coinfection, and more.......[Read More]

In this paper from AIDS, learn more about the effects of a novel growth hormone releasing factor on abdominal fat accumulation and metabolic and safety parameters in HIV-infected patients with central......[Read More]

Do sex or race influence risk for other conditions in elderly HIV patients?......[Read More]